CladribineUse in Therapy of Multiple Sclerosis

被引:0
|
作者
John S. Romine
Jack C. Sipe
James A. Koziol
Jack Zyroff
Robert McMillan
Ernest Beutler
机构
[1] Scripps Clinic and Research Foundation,Division of Neurology
[2] The Scripps Research Institute,Department of Molecular and Experimental Medicine
[3] Scripps Clinic and Research Foundation,Division of Radiology
来源
BioDrugs | 1997年 / 7卷
关键词
Multiple Sclerosis; Multiple Sclerosis Patient; Herpes Zoster; Expand Disability Status Scale; Cladribine;
D O I
暂无
中图分类号
学科分类号
摘要
Cladribine is a novel drug that selectively depletes lymphocytes and may be able to destroy the activated immunocytes that damage the central nervous system in multiple sclerosis. Our initial controlled studies have shown a beneficial, although temporary, dose-related effect of cladribine on the course of chronic progressive multiple sclerosis.
引用
收藏
页码:386 / 393
页数:7
相关论文
共 50 条
  • [1] Fingolimod Therapy for Multiple Sclerosis
    Willis, Mary A.
    Cohen, Jeffrey A.
    SEMINARS IN NEUROLOGY, 2013, 33 (01) : 37 - 44
  • [2] Symptomatic therapy in multiple sclerosis
    Mancardi, Giovanni Luigi
    NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 4) : S287 - S287
  • [3] Alemtuzumab Therapy for Multiple Sclerosis
    Alasdair J. Coles
    Neurotherapeutics, 2013, 10 : 29 - 33
  • [4] Immunomodulatory therapy of multiple sclerosis
    Weber, F
    NERVENHEILKUNDE, 2000, 19 (06) : 310 - 315
  • [5] Natalizumab therapy of multiple sclerosis
    Hutchinson, Michael
    CYTOKINE, 2009, 48 (1-2) : 22 - 22
  • [6] Concomitant therapy for multiple sclerosis
    Stuart, WH
    Vermersch, P
    NEUROLOGY, 2004, 63 (11) : S28 - S34
  • [7] Interferon β therapy for multiple sclerosis
    Goodkin, DE
    LANCET, 1998, 352 (9139): : 1486 - 1487
  • [8] Interferon therapy of multiple sclerosis
    Hohlfeld, R
    ADVANCES AND CONTINUING EDUCATION IN MEDICINE, VOL 20, (1996/97), 1996, 20 : 211 - 213
  • [9] The future of multiple sclerosis therapy
    Kieseier, Bernd C.
    Wiendl, Heinz
    Hartung, Hans-Peter
    Stueve, Olaf
    PHARMACOLOGICAL RESEARCH, 2009, 60 (04) : 207 - 211
  • [10] THERAPY OF MULTIPLE-SCLEROSIS
    JERUSALEM, F
    WUTHRICH, R
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1980, 69 (11): : 349 - 354